4/A//SEC Filing
Evans Terry L 4/A
Accession 0001415889-25-010067
CIK 0001211583other
Filed
Apr 2, 8:00 PM ET
Accepted
Apr 3, 7:14 PM ET
Size
6.3 KB
Accession
0001415889-25-010067
Insider Transaction Report
Form 4/AAmended
Evans Terry L
Chief Commercial Officer
Transactions
- Award
Restricted Share Unit
2025-03-28+10,000→ 160,000 totalExercise: $0.00From: 2026-03-28Exp: 2035-03-28→ Common Shares (10,000 underlying)
Footnotes (2)
- [F1]On March 28, 2025,Terry Evans was awarded restricted share units to acquire 10,000 shares of the issuer's common shares pursuant to the issuer's 2020 Equity Incentive Plan.
- [F2]One-third of the shares subject to this award shall be released from restriction as of March 28, 2026 (the "Vesting Commencement Date"). One twenty-fourth of the shares subject to this award may be released from restriction as of the last day of each month following the Vesting Commencement Date. As of February 29, 2028 and thereafter, 100% of the total number of shares subject to this award shall be released from restriction.
Documents
Issuer
FENNEC PHARMACEUTICALS INC.
CIK 0001211583
Entity typeother
Related Parties
1- filerCIK 0002043317
Filing Metadata
- Form type
- 4/A
- Filed
- Apr 2, 8:00 PM ET
- Accepted
- Apr 3, 7:14 PM ET
- Size
- 6.3 KB